DEPAKOTE DR 125 MG TABLET

Divalproex Sodium
$2.0566per EA
High Outlier

Strength

125 mg/1

Manufacturer

AbbVie Inc.

NDC

00074732513

Classification

Brand

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Last Updated

1/2/2026

Active Ingredients

DIVALPROEX SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA018723

On Market Since

3/10/1983

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Mood Stabilizer

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+5.1%

1Y

+4.0%

3Y

+14.9%

5Y

N/A

All

+14.9%